Research suggests need for long-term follow-up for patients with Kawasaki Disease

9 Sep 2015, 4:57 p.m.

Photo of Paul Brogan

Kawasaki disease is a rare condition that causes blood vessels to become inflamed and swollen. It predominantly occurs in children under the age of five. If left untreated, it results in balloon-like swellings (aneurysms) in the coronary vessels of approximately 25% of cases. To date, the cause of this disease remains unknown. A group of researchers led by Dr Paul Brogan recently conducted a study aiming to shed light on how the disease develops. Ninety-two children with KD were examined at the Somers Clinical Research Facility (CRF) at GOSH. Levels of circulating endothelial cells (CECs), which are mature cells that have become detached from the vessel wall and are often associated with vascular injury, were measured years after patients developed KD.

The researchers found CECs were elevated in KD patients, usually highest in patients with coronary artery aneurysms. Elevated levels of CECs were also seen in some KD patients that had not had coronary artery aneurysms. While the relevance of elevated CECs are not yet known, this study provides rationale for long-term follow up of these patients.

This study has been accepted for publication in the journal, Heart. It was conducted at the BRC-supported Somers CRF at GOSH. Dr Brogan is a BRC-supported researcher.

GOSH and Amazon Web Services collaborate to drive digital innovation across care, research and education

GOSH and AWS have signed a Strategic Collaboration Agreement, demonstrating a shared ambition to enhance clinical care, operations, research and education through digital advancements.

Moving from Code to Clinic: how GOSH and Roche are turning data into better care

Our 5-year partnership with Roche has brought together expertise in clinical care, AI and data science to help unlock insights from complex healthcare data in a safe and secure way. Watch our new animation to learn more about the journey from code to clin

World-first same-day metagenomics for children can detect hidden infections in intensive care

GOSH has successfully implemented a pioneering same-day respiratory metagenomics testing service for children in intensive care, helping clinicians identify infections more quickly and make better-informed treatment decision

GOSH families at the heart of major £6m project to improve support for children with complex needs

Children, young people and families from GOSH will help shape a major new research programme